Search results for "aspartate"

showing 10 items of 195 documents

A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics

2011

Glutamate excitotoxicity leads to fragmented mitochondria in neurodegenerative diseases, mediated by nitric oxide and S-nitrosylation of dynamin-related protein 1, a mitochondrial outer membrane fission protein. Optic atrophy gene 1 (OPA1) is an inner membrane protein important for mitochondrial fusion. Autosomal dominant optic atrophy (ADOA), caused by mutations in OPA1, is a neurodegenerative disease affecting mainly retinal ganglion cells (RGCs). Here, we showed that OPA1 deficiency in an ADOA model influences N-methyl-D-aspartate (NMDA) receptor expression, which is involved in glutamate excitotoxicity and oxidative stress. Opa1enu/+mice show a slow progressive loss of RGCs, activation …

Retinal Ganglion CellsCancer ResearchReceptor expressionExcitotoxicityApoptosisNeurodegenerativeMitochondrionEyemedicine.disease_causeGTP PhosphohydrolasesMice0302 clinical medicineReceptorsoxidative stressPhosphorylationbcl-2-Associated X Protein0303 health sciencesbiologyGlutamate receptorMitochondriaUp-RegulationCell biologymitochondrial fusionAutosomal DominantOriginal Articlebcl-Associated Death ProteinMitochondrial fissionN-Methyl-D-AspartateBiotechnologymitochondrial fragmentationOncology and CarcinogenesisImmunologybcl-X ProteinSOD2Glutamic AcidReceptors N-Methyl-D-AspartateNMDA receptorsCell Line03 medical and health sciencesCellular and Molecular NeuroscienceBcl-2-associated X proteinOptic Atrophy Autosomal DominantmedicineAnimalsEye Disease and Disorders of Vision030304 developmental biologySuperoxide DismutaseNeurosciencesCell BiologyMolecular biologyeye diseasesOxidative StressOptic AtrophyMutationbiology.proteinOPA1 mutationBiochemistry and Cell Biologysense organsglutamate excitotoxicity030217 neurology & neurosurgeryCell Death & Disease
researchProduct

Synthesis and pharmacological evaluation of several ring-contracted amantadine analogs

2008

Graphical abstract Several bisnoradamantylamines and noradamantylamines have been synthesized and their antiviral, trypanocidal, NMDA receptor antagonist, and dopamine reuptake inhibitory activities have been studied.

RimantadineStereochemistryDopamineeducationClinical BiochemistryPharmaceutical Sciencemacromolecular substancesPharmacologymedicine.disease_causeAntiviral AgentsReceptors N-Methyl-D-AspartateBiochemistryChemical synthesisArticleInhibitory Concentration 50DogsPolycyclic compoundMemantineTrypanosomiasisDopamineDrug DiscoveryAmantadinemedicineInfluenza A virusAnimalsNMDA receptor antagonistMolecular BiologyCells Culturedchemistry.chemical_classificationChemistryOrganic ChemistryAmantadinePolycyclic cage compoundsBiological activityInfluenzanervous systemInfluenza A virusMolecular MedicineNMDA receptormedicine.drugBioorganic & Medicinal Chemistry
researchProduct

Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance

2022

Background & Aims Serum microRNA (miRNA) levels are known to change in non-alcoholic fatty liver disease (NAFLD) and may serve as useful biomarkers. This study aimed to profile miRNAs comprehensively at all NAFLD stages. Methods We profiled 2,083 serum miRNAs in a discovery cohort (183 cases with NAFLD representing the complete NAFLD spectrum and 10 population controls). miRNA libraries generated by HTG EdgeSeq were sequenced by Illumina NextSeq. Selected serum miRNAs were profiled in 372 additional cases with NAFLD and 15 population controls by quantitative reverse transcriptase PCR. Results Levels of 275 miRNAs differed between cases and population controls. Fewer differences were seen wi…

SCORING SYSTEMCPM counts per millionAUROC area under the receiver operating characteristicRC799-869AST aspartate aminotransferaseMicroRNA; Non-alcoholic fatty liver disease; Biomarker; SequencingTGF-β transforming growth factor-betaGastroenterologySTEATOHEPATITISLiver disease0302 clinical medicineFibrosismiRNA microRNAlogFC log2 fold changeFIBROSISImmunology and AllergySequencing0303 health scienceseducation.field_of_studyNAS NAFLD activity scoremedicine.diagnostic_testFatty liverGastroenterologyGTEx Genotype-Tissue ExpressionMicroRNADiseases of the digestive system. Gastroenterology3. Good healthReal-time polymerase chain reactionBiomarker MicroRNA Non-alcoholic fatty liver disease SequencingLiver biopsyACIDBiomarker (medicine)030211 gastroenterology & hepatologyLife Sciences & BiomedicineResearch ArticleEXPRESSIONmedicine.medical_specialtyNAFLD non-alcoholic fatty liver diseaseNASH non-alcoholic steatohepatitisPopulationGastroenterology and HepatologySAF steatosis–activity–fibrosisVALIDATIONER endoplasmic reticulum03 medical and health sciencescDNA complementary DNAInternal medicineALT alanine aminotransferaseGastroenterologiInternal MedicinemedicineNAFL non-alcoholic fatty liverALGORITHMFIB-4 fibrosis-4education030304 developmental biologyPCA principal component analysisScience & TechnologyGastroenterology & HepatologyHepatologybusiness.industryBiomarkerFC fold changemedicine.diseaseBiomarker; MicroRNA; Non-alcoholic fatty liver disease; Sequencingdigestive system diseasesFLIP fatty liver inhibition of progressionCt cycle thresholdSteatosisqPCR quantitative PCRbusinessNon-alcoholic fatty liver disease
researchProduct

Xenon treatment improves short-term and long-term outcomes in a rodent model of traumatic brain injury

2018

Science & TechnologyTraumatic brain injurybusiness.industrySITE1103 Clinical SciencesRodent modelmedicine.diseaseCOMPETITIVE-INHIBITIONTerm (time)D-ASPARTATE RECEPTORAnesthesiology and Pain MedicineAnesthesiologyAnesthesiamedicineLong term outcomesbusinessLife Sciences & BiomedicineBritish Journal of Anaesthesia
researchProduct

Binuclear Cu2+ complex mediated discrimination between L-glutamate and L-aspartate in water.

2005

L-Glutamate and L-aspartate selectivity is achieved by the action of two Cu2+ metal ions rightly disposed in a cyclophanetype macrocyclic framework; electrochemical sensing of glutamate has been achieved by adsorption of the copper complexes on graphite electrodes. Verdejo Viu, Begoña, Begona.Verdejo@uv.es ; Domenech Carbo, Antonio, Antonio.Domenech@uv.es ; Jimenez Garcia, Hermas Rafael, Hermas.Jimenez@uv.es ; Soriano Soto, Concepción, Concepcion.Soriano@uv.es ; Garcia-España Monsonis, Enrique, Enrique.Garcia-Es@uv.es

StereochemistryUNESCO::QUÍMICAMetal ions in aqueous solutionL-Aspartatechemistry.chemical_elementGlutamic AcidElectrochemistry:QUÍMICA [UNESCO]Medicinal chemistryCatalysisAdsorptionMaterials ChemistryElectrochemistryOrganometallic CompoundsAspartic AcidUNESCO::QUÍMICA::Química inorgánicaElectrochemicalMetals and AlloysGlutamate receptorWaterBinuclear Cu2General ChemistryCyclophanetype macrocyclic framework:QUÍMICA::Química inorgánica [UNESCO]CopperSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialschemistryL glutamateL-aspartateBinuclear Cu2 ; L-glutamate ; L-aspartate ; Water ; Cyclophanetype macrocyclic framework ; ElectrochemicalCeramics and CompositesL-glutamateSelectivityCopperChemical communications (Cambridge, England)
researchProduct

Taspase1: a 'misunderstood' protease with translational cancer relevance

2015

Proteolysis is not only a critical requirement for life, but the executing enzymes also play important roles in numerous pathological conditions, including cancer. Therefore, targeting proteases is clearly relevant for improving cancer patient care. However, to effectively control proteases, a profound knowledge of their mechanistic function as well as their regulation and downstream signalling in health and disease is required. The highly conserved protease Threonine Aspartase1 (Taspase1) is overexpressed in numerous liquid and solid malignancies and was characterized as a 'non-oncogene addiction' protease. Although Taspase1 was shown to cleave various regulatory proteins in humans as well…

Threonine0301 basic medicineCancer ResearchProteasesmedicine.medical_treatmentProteolysisComputational biologyDiseaseBiologyBioinformaticsmedicine.disease_causeAspartate Ammonia-LyaseGene Expression Regulation EnzymologicTranslational Research Biomedical03 medical and health sciencesNeoplasmsEndopeptidasesGeneticsmedicineHumansEnzyme InhibitorsMolecular BiologyProteaseMolecular Structuremedicine.diagnostic_testCancermedicine.diseaseGene Expression Regulation Neoplastic030104 developmental biologyProteasomeCarcinogenesisBiologieFunction (biology)Oncogene
researchProduct

Results of the TOP Study: Prospectively Randomized Multicenter Trial of an Ex Vivo Tacrolimus Rinse Before Transplantation in EDC Livers

2016

Background. Organ shortage results in the transplantation of extended donor criteria (EDC) livers which is associated with increased ischemia-reperfusion injury (IRI). Experimental studies indicate that an organ rinse with the calcineurin inhibitor tacrolimus before implantation protects against IRI. The tacrolimus organ perfusion study was initiated to examine the effects of ex vivo tacrolimus perfusion on IRI in transplantation of EDC livers. Methods. A prospective randomized multicenter trial comparing ex vivo perfusion of marginal liver grafts (>= 2 EDC according to Eurotransplant manual) with tacrolimus (20 ng/mL) or histidine-tryptophane-ketoglutarate solution (control) was carried ou…

Transplantationmedicine.medical_specialtybiologybusiness.industryUrologyAspartate transaminase030230 surgeryInterim analysisTacrolimusLiver TransplantationSurgeryTransplantationCalcineurin03 medical and health sciencessurgical procedures operative0302 clinical medicineAlanine transaminaseMulticenter trialbiology.proteinmedicineClinical endpoint030211 gastroenterology & hepatologybusinessTransplantation Direct
researchProduct

Co-activation of VEGF and NMDA receptors promotes synaptic targeting of AMPA receptors

2016

Vascular Endothelial Growth Factor A0301 basic medicineVEGF receptorsAMPA receptorHippocampusReceptors N-Methyl-D-Aspartate030226 pharmacology & pharmacy03 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicinemedicineAnimalsDementiaReceptorMolecular BiologyNeuronsbiologyChemistrySynapsinsmedicine.diseasePsychiatry and Mental health030104 developmental biologySchizophreniaSynapsesBehavioral medicinebiology.proteinNMDA receptorPsychopharmacologyDisks Large Homolog 4 ProteinNeuroscienceMolecular Psychiatry
researchProduct

A critical role for VEGF and VEGFR2 in NMDA receptor synaptic function and fear-related behavior

2016

Vascular endothelial growth factor (VEGF) is known to be required for the action of antidepressant therapies but its impact on brain synaptic function is poorly characterized. Using a combination of electrophysiological, single-molecule imaging and conditional transgenic approaches, we identified the molecular basis of the VEGF effect on synaptic transmission and plasticity. VEGF increases the postsynaptic responses mediated by the N-methyl-D-aspartate type of glutamate receptors (GluNRs) in hippocampal neurons. This is concurrent with the formation of new synapses and with the synaptic recruitment of GluNR expressing the GluN2B subunit (GluNR-2B). VEGF induces a rapid redistribution of Glu…

Vascular Endothelial Growth Factor A0301 basic medicine[SDV]Life Sciences [q-bio]Cell Culture TechniquesNonsynaptic plasticityBiologyNeurotransmissionHippocampusReceptors N-Methyl-D-AspartateSynaptic TransmissionMice03 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicinePostsynaptic potentialAnimalsddc:610Molecular BiologyComputingMilieux_MISCELLANEOUSNeuronsNeuronal PlasticityBehavior AnimalGlutamate receptorExcitatory Postsynaptic PotentialsKinase insert domain receptorFearVascular Endothelial Growth Factor Receptor-2Protein SubunitsPsychiatry and Mental health030104 developmental biologySynaptic fatigueReceptors GlutamateSynapsesSynaptic plasticityNMDA receptorOriginal ArticleNeuroscience030217 neurology & neurosurgery
researchProduct

Electrophysiological and morphological properties of Cajal–Retzius cells with different ontogenetic origins

2010

International audience; The different origins of Cajal-Retzius cells (CRc) as well as their diverse molecular profile suggest that this cell type may represent different neuronal subpopulations. In order to investigate whether CRc from different origins show distinct functional or morphological characteristics we used transgenic Dbx1(cre);ROSA26(YFP) mice in which two subpopulations of CRc, originating from the septum and ventral pallium (VP) at the pallial-subpallial border (PSB), were permanently labeled by yellow fluorescent protein (YFP) expression. Electrophysiological properties of YFP(+) and YFP(-) CRc were investigated by whole-cell patch-clamp recordings, while a thorough somatoden…

Yellow fluorescent proteinCell typePatch-Clamp TechniquesNeurogenesisAction PotentialsGlutamic AcidMice Transgenicmacromolecular substancesReceptors N-Methyl-D-AspartateMembrane PotentialsMice03 medical and health scienceschemistry.chemical_compoundOrgan Culture Techniques0302 clinical medicineBiocytinAnimalsCell LineagePatch clampCell Shapegamma-Aminobutyric AcidImage Cytometry030304 developmental biologyCerebral CortexNeurons0303 health sciencesbiologyStem CellsGeneral NeurosciencefungiCell DifferentiationDendritesHyperpolarization (biology)digestive system diseasesCell biologyLuminescent ProteinsElectrophysiologynervous systemchemistrybiology.proteinGABAergic[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]DBX1Nerve NetExcitatory Amino Acid Antagonists030217 neurology & neurosurgeryNeuroscience
researchProduct